Home › Triple-Negative Breast Cancer › New Jersey › Edison
Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa Edison, NJ
Isang pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Edison. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- START New Jersey, East Brunswick · 6 mi ang layo
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Nagre-recruit
- Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township · 5 mi ang layo
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Nagre-recruitPhase 3
- Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick · 3 mi ang layo
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
Nagre-recruitPhase 1
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Nagre-recruitPhase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi ang layo
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Nagre-recruitPhase 3
- Rutgers Health, New Brunswick · 3 mi ang layo
- Regional Cancer Care Associates LLC, East Brunswick · 6 mi ang layo
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
Nagre-recruitPhase 2
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Nagre-recruitPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Nagre-recruitPhase 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
Nagre-recruitPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Nagre-recruitPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
Pag-aaral para sa Triple-Negative Breast Cancer sa ibang lungsod
- Houston, TX42 pag-aaral
- New York City, NY31 pag-aaral
- Nashville, TN28 pag-aaral
- Los Angeles, CA27 pag-aaral
- Boston, MA26 pag-aaral
- San Antonio, TX23 pag-aaral
- St. Louis, MO21 pag-aaral
- Arlington, VA20 pag-aaral
- Atlanta, GA20 pag-aaral
- Dallas, TX18 pag-aaral
- Chicago, IL16 pag-aaral
- Columbus, OH16 pag-aaral
Iba pang pag-aaral sa Edison
- Kanser sa Suso68 pag-aaral
- Non-Small Cell Lung Cancer47 pag-aaral
- Kanser (lahat ng uri)33 pag-aaral
- Kanser sa Prostate29 pag-aaral
- Colorectal Cancer23 pag-aaral
- Kanser sa Baga23 pag-aaral
- Multiple Myeloma22 pag-aaral
- Kanser sa Pantog21 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
- Kanser sa Ovary20 pag-aaral
- Metastatic Cancer20 pag-aaral
- Kanser ng Endometrium19 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.